LivaNova (NASDAQ:LIVN) is a global medical technology company focused on developing innovative solutions that improve patient outcomes and enhance lives. The company operates two primary business segments: Cardiovascular and Neuromodulation. In the cardiovascular realm, LivaNova is dedicated to advancing technology for cardiac surgery, including heart valve therapy, and cardiopulmonary solutions. On the neuromodulation front, the company is a pioneer in offering devices designed to treat epilepsy and depression, aiming to address some of the most challenging areas of unmet medical needs. With a commitment to clinical excellence and innovation, LivaNova's projects and objectives are centered around transforming the standard of care for patients around the world, driving sustainable growth, and extending its reach into new markets to improve more lives with their medical technologies.